You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Malignant Mesothelioma

Showing 1 - 25 of 4,277
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lung Cancer, Mesothelioma Trial in Houston (Alisertib)

Completed
Has Results
  • Lung Cancer
  • Mesothelioma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 23, 2022

Cancer, Cancer, Lung, Cancer of Lung Trial in Worldwide (UV1 vaccine + leukine, ipilimumab, nivolumab)

Active, not recruiting
  • Cancer
  • +6 more
  • UV1 vaccine + leukine
  • +2 more
  • Perth, Australia
  • +6 more
Jan 23, 2023

Biphasic Mesothelioma, Epithelioid Mesothelioma, Peritoneal Malignant Mesothelioma Trial in Chicago (Pembrolizumab, Laboratory

Active, not recruiting
  • Biphasic Mesothelioma
  • +9 more
  • Pembrolizumab
  • +2 more
  • Chicago, Illinois
    University of Chicago
Apr 18, 2022

Mesothelioma Trial run by the National Cancer Institute (NCI) (LMB-100, nab-paclitaxel)

Completed
Has Results
  • Mesothelioma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 28, 2022

Mesothelioma, Malignant Mesothelioma (MM), Early-stage Mesothelioma Trial run by the National Cancer Institute (NCI)

Not yet recruiting
  • Mesothelioma
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 1, 2023

Biological Characteristics of Mesothelioma Patients

Completed
  • Malignant Mesothelioma
    • Rozzano, Milano, Italy
    • +1 more
    Sep 8, 2022

    Mesothelioma Trial run by the National Cancer Institute (NCI) (LMB-100, ipilimumab)

    Recruiting
    • Mesothelioma
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jul 6, 2022

    Malignant Peritoneal Mesothelioma, Peritoneal Mesothelioma, Mesothelioma Trial in United States (Pemetrexed, Cisplatin,

    Recruiting
    • Malignant Peritoneal Mesothelioma
    • +4 more
    • Chicago, Illinois
    • +10 more
    Sep 21, 2023

    Peritoneal Malignant Mesothelioma Trial in Rotterdam (Intraperitoneal Paclitaxel Solution (Ml))

    Recruiting
    • Peritoneal Malignant Mesothelioma
    • Intraperitoneal Paclitaxel Solution (Ml)
    • Rotterdam, Zuid-Holland, Netherlands
      Erasmus Medical Center
    Jul 7, 2022

    Study of Patients With Malignant Mesothelioma

    Recruiting
    • Mesothelioma
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Apr 7, 2022

      Pleural Malignant Mesothelioma Trial in Houston (other, radiation, biological)

      Recruiting
      • Pleural Malignant Mesothelioma
      • Laboratory Biomarker Analysis
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      May 13, 2022

      Non Small Cell Lung Cancer, Non-squamous Non-small-cell Lung Cancer, Urothelial Carcinoma Trial in Augusta (Cabozantinib,

      Recruiting
      • Non Small Cell Lung Cancer
      • +3 more
      • Augusta, Georgia
        Augusta University Georgia Cancer Center
      Mar 6, 2022

      Mesothelioma, Malignant Trial in Leicester (Rucaparib, Abemaciclib, pembrolizumab & bemcentinib)

      Recruiting
      • Mesothelioma, Malignant
      • Leicester, United Kingdom
        University Hospitals of Leicester NHS Trust
      Apr 6, 2022

      Histologic Prognostic Factors in Peritoneal Malignant

      Recruiting
      • Peritoneal Malignant Mesothelioma
      • No intervention
      • Gent, Belgium
      • +5 more
      Dec 31, 2021

      Oncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in

      Recruiting
      • Malignant Pleural Mesothelioma, Advanced
      • Oncolytic Adenovirus H101
      • Programmed death receptor-1 inhibitor
      • Tianjin, Tianjin, China
        Tianjin Medical Unversity Second Hospital
      Sep 2, 2023

      Malignant Pleural Mesothelioma Trial (Proton beam therapy)

      Not yet recruiting
      • Malignant Pleural Mesothelioma
      • Proton beam therapy
      • (no location specified)
      Dec 14, 2022

      Malignant Pleural Mesothelioma Trial in Cairo (Gemcitabine, supportive care)

      Not yet recruiting
      • Malignant Pleural Mesothelioma
      • Cairo, Egypt
        Ain Shams University Hospital
      Dec 20, 2022

      Malignant Mesothelioma (MPM) Trial in United States (Avelumab, Stereotactic Body Radiation Therapy)

      Active, not recruiting
      • Malignant Mesothelioma (MPM)
      • Avelumab
      • Stereotactic Body Radiation Therapy
      • Basking Ridge, New Jersey
      • +6 more
      Mar 7, 2022

      CD30-Positive Neoplastic Cells Present, Malignant Mesothelioma Trial in Houston (Brentuximab Vedotin, Laboratory Biomarker

      Recruiting
      • CD30-Positive Neoplastic Cells Present
      • Malignant Mesothelioma
      • Brentuximab Vedotin
      • Laboratory Biomarker Analysis
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 3, 2022

      Mesothelioma Trial run by the NCI (LMB-100, Pembrolizumab)

      Terminated
      Has Results
      • Mesothelioma
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Nov 3, 2021

      Patients With Mesothelioma

      Not yet recruiting
      • Mesothelioma
        • (no location specified)
        Apr 21, 2023

        Mesotheliomas Pleural Trial in Amsterdam (Pembrolizumab, Lenvatinib)

        Recruiting
        • Mesotheliomas Pleural
        • Amsterdam, Noord-Holland, Netherlands
          Antoni van Leeuwenhoekziekenhuis (NKI-AVL)
        Jan 13, 2023

        Malignant Pleural Mesothelioma, Mesothelioma Trial in Tampa (Cisplatin, Methotrexate, Gemcitabine)

        Active, not recruiting
        Has Results
        • Malignant Pleural Mesothelioma
        • Mesothelioma
        • Tampa, Florida
          H. Lee Moffitt Cancer Center and Research Institute
        Jan 5, 2023

        Malignant Pleural Mesothelioma Trial in Edegem, Ghent, Sint-Niklaas (Dendritic cell vaccination, Atezolizumab,

        Not yet recruiting
        • Malignant Pleural Mesothelioma
        • Dendritic cell vaccination
        • +2 more
        • Edegem, Antwerp, Belgium
        • +2 more
        Feb 28, 2023

        Malignant Abdominal Tumor, Malignant Pelvic Tumor, Recurrent Colon Carcinoma Trial in Rochester (Cisplatin, Cytoreductive

        Recruiting
        • Malignant Abdominal Neoplasm
        • +26 more
        • Rochester, Minnesota
          Mayo Clinic in Rochester
        Jan 5, 2023